Avidity Biosciences (RNA) Profit After Tax: 2019-2025
Historic Profit After Tax for Avidity Biosciences (RNA) over the last 7 years, with Sep 2025 value amounting to -$174.4 million.
- Avidity Biosciences' Profit After Tax fell 116.97% to -$174.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$549.8 million, marking a year-over-year decrease of 96.01%. This contributed to the annual value of -$322.3 million for FY2024, which is 51.87% down from last year.
- According to the latest figures from Q3 2025, Avidity Biosciences' Profit After Tax is -$174.4 million, which was down 10.89% from -$157.3 million recorded in Q2 2025.
- In the past 5 years, Avidity Biosciences' Profit After Tax registered a high of -$23.8 million during Q1 2021, and its lowest value of -$174.4 million during Q3 2025.
- Over the past 3 years, Avidity Biosciences' median Profit After Tax value was -$70.8 million (recorded in 2024), while the average stood at -$89.3 million.
- Data for Avidity Biosciences' Profit After Tax shows a maximum YoY tumbled of 291.85% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Avidity Biosciences' Profit After Tax stood at -$38.5 million in 2021, then slumped by 30.96% to -$50.5 million in 2022, then declined by 19.76% to -$60.4 million in 2023, then plummeted by 69.18% to -$102.3 million in 2024, then plummeted by 116.97% to -$174.4 million in 2025.
- Its Profit After Tax stands at -$174.4 million for Q3 2025, versus -$157.3 million for Q2 2025 and -$115.8 million for Q1 2025.